Regenxbio Inc (NAS:RGNX)
$ 8.92 0.16 (1.83%) Market Cap: 440.86 Mil Enterprise Value: 228.13 Mil PE Ratio: 0 PB Ratio: 1.26 GF Score: 65/100

Regenxbio Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 05:30PM GMT
Release Date Price: $20.24 (-0.49%)
Matt Galle
(Trades, Portfolio), Inc. - Moderator

Good afternoon, everyone. Welcome to the Jefferies Global Healthcare Conference. My name is Matt Galle, part of the Jefferies Healthcare Investment Banking team.

It's my pleasure to introduce Ken Mills, President and CEO, REGENXBIO, to give the presentation today. Thank you.

Ken Mills
REGENXBIO Inc. - President, CEO

Thanks, Matt. Thanks to all the folks at Jefferies, the organizers, and also Matt Kim on the banking team, who's always a strong advocate for us at for REGENXBIO. Start here with the mention of forward-looking statements. There may be some statements that I make about future projections about operations or REGENXBIO today, to the extent that you need any further clarification on these

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot